Terms: = Sarcomas AND NF2, ACN, 4771, ENSG00000186575, P35240, SCH, Merlin, BANF AND Treatment
22 results:
1. Acquired nf2 mutation confers resistance to TRK inhibition in an ex vivo LMNA::NTRK1-rearranged soft-tissue sarcoma cell model.
Chen Y; Steiner S; Hagedorn C; Kollar S; Pliego-Mendieta A; Haberecker M; Plock J; Britschgi C; Planas-Paz L; Pauli C
J Pathol; 2024 Jun; 263(2):257-269. PubMed ID: 38613194
[TBL] [Abstract] [Full Text] [Related]
2. treatment and prognostic implications of strong PD-L1 expression in primary hepatic sarcomatoid carcinoma.
Radhakrishnan S; Martin CA; Vij M; Subbiah K; Raju LP; Gowrishankar G; Veldore VH; Kaliamoorthy I; Rammohan A; Rela M
Immunotherapy; 2024 Apr; 16(6):371-379. PubMed ID: 38362631
[TBL] [Abstract] [Full Text] [Related]
3. Expanding a precision medicine platform for malignant peripheral nerve sheath tumors: New patient-derived orthotopic xenografts, cell lines and tumor entities.
Creus-Bachiller E; Fernández-Rodríguez J; Magallón-Lorenz M; Ortega-Bertran S; Navas-Rutete S; Romagosa C; Silva TM; Pané M; Estival A; Perez Sidelnikova D; Morell M; Mazuelas H; Carrió M; Lausová T; Reuss D; Gel B; Villanueva A; Serra E; Lázaro C
Mol Oncol; 2024 Apr; 18(4):895-917. PubMed ID: 37798904
[TBL] [Abstract] [Full Text] [Related]
4. [Neurofibromatosis].
Matthies C; Rampeltshammer E; Breun M
Fortschr Neurol Psychiatr; 2023 May; 91(5):213-232. PubMed ID: 37192611
[TBL] [Abstract] [Full Text] [Related]
5. CD44 Contributes to the Regulation of MDR1 Protein and Doxorubicin Chemoresistance in Osteosarcoma.
Gerardo-Ramírez M; Keggenhoff FL; Giam V; Becker D; Groth M; Hartmann N; Straub BK; Morrison H; Galle PR; Marquardt JU; Herrlich P; Hartmann M
Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955749
[TBL] [Abstract] [Full Text] [Related]
6. Primary central nervous system histiocytic sarcoma with somatic
Wang W; Zhang Y; Dong Y; Li S; Qin H
Clin Neuropathol; 2022; 41(6):253-262. PubMed ID: 35652545
[TBL] [Abstract] [Full Text] [Related]
7. Detection of malignant peripheral nerve sheath tumors in patients with neurofibromatosis using aneuploidy and mutation identification in plasma.
Mattox AK; Douville C; Silliman N; Ptak J; Dobbyn L; Schaefer J; Popoli M; Blair C; Judge K; Pollard K; Pratilas C; Blakeley J; Rodriguez F; Papadopoulos N; Belzberg A; Bettegowda C
Elife; 2022 Mar; 11():. PubMed ID: 35244537
[TBL] [Abstract] [Full Text] [Related]
8. schisandrin B suppresses osteosarcoma lung metastasis
Wang Y; Chen J; Huang Y; Yang S; Tan T; Wang N; Zhang J; Ye C; Wei M; Luo J; Luo X
Oncol Rep; 2022 Mar; 47(3):. PubMed ID: 35029287
[TBL] [Abstract] [Full Text] [Related]
9. RKIP Induction Promotes Tumor Differentiation via SOX2 Degradation in nf2-Deficient Conditions.
Cho JH; Park S; Kim S; Kang SM; Woo TG; Yoon MH; Lee H; Jeong M; Park YH; Kim H; Han YT; Suh YG; Kim BH; Kwon Y; Yun H; Park BJ
Mol Cancer Res; 2022 Mar; 20(3):412-424. PubMed ID: 34728553
[TBL] [Abstract] [Full Text] [Related]
10. Sarcomatous Meningioma: Diagnostic Pitfalls and the Utility of Molecular Testing.
Lucas CG; Devine P; Solomon DA; Giannini C; Reifenberger G; Dahiya S; Caccamo D; Perry A
J Neuropathol Exp Neurol; 2021 Sep; 80(8):764-768. PubMed ID: 34128073
[TBL] [Abstract] [Full Text] [Related]
11. Intracranial metastasis from a malignant peripheral nerve sheath tumor in a patient with neurofibromatosis type 1: A case study and literature review.
Griffin S; Witt MC; El Tecle N; Prim M; Hockman J; Schwetye KE; Pierson MJ
Clin Neurol Neurosurg; 2021 Apr; 203():106540. PubMed ID: 33607580
[TBL] [Abstract] [Full Text] [Related]
12. Clinicopathological variables of sporadic schwannomas of peripheral nerve in 291 patients and expression of biologically relevant markers.
Young ED; Ingram D; Metcalf-Doetsch W; Khan D; Al Sannaa G; Le Loarer F; Lazar AJF; Slopis J; Torres KE; Lev D; Pollock RE; McCutcheon IE
J Neurosurg; 2018 Sep; 129(3):805-814. PubMed ID: 28885122
[TBL] [Abstract] [Full Text] [Related]
13. The effect and mechanism of dopamine D1 receptors on the proliferation of osteosarcoma cells.
Gao J; Zhang C; Gao F; Li H
Mol Cell Biochem; 2017 Jun; 430(1-2):31-36. PubMed ID: 28181134
[TBL] [Abstract] [Full Text] [Related]
14. A phase II study of clinical activity of sch 717454 (robatumumab) in patients with relapsed osteosarcoma and Ewing sarcoma.
Anderson PM; Bielack SS; Gorlick RG; Skubitz K; Daw NC; Herzog CE; Monge OR; Lassaletta A; Boldrini E; Pápai Z; Rubino J; Pathiraja K; Hille DA; Ayers M; Yao SL; Nebozhyn M; Lu B; Mauro D
Pediatr Blood Cancer; 2016 Oct; 63(10):1761-70. PubMed ID: 27362300
[TBL] [Abstract] [Full Text] [Related]
15. Personalized comprehensive molecular profiling of high risk osteosarcoma: Implications and limitations for precision medicine.
Subbiah V; Wagner MJ; McGuire MF; Sarwari NM; Devarajan E; Lewis VO; Westin S; Kato S; Brown RE; Anderson P
Oncotarget; 2015 Dec; 6(38):40642-54. PubMed ID: 26510912
[TBL] [Abstract] [Full Text] [Related]
16. Potential of boron neutron capture therapy (BNCT) for malignant peripheral nerve sheath tumors (MPNST).
Fujimoto T; Andoh T; Sudo T; Fujita I; Fukase N; Takeuchi T; Sonobe H; Inoue M; Hirose T; Sakuma T; Moritake H; Sugimoto T; Kawamoto T; Fukumori Y; Yamamoto S; Atagi S; Sakurai Y; Kurosaka M; Ono K; Ichikawa H; Suzuki M
Appl Radiat Isot; 2015 Dec; 106():220-5. PubMed ID: 26278348
[TBL] [Abstract] [Full Text] [Related]
17. Phase I dose-escalation trial of checkpoint kinase 1 inhibitor MK-8776 as monotherapy and in combination with gemcitabine in patients with advanced solid tumors.
Daud AI; Ashworth MT; Strosberg J; Goldman JW; Mendelson D; Springett G; Venook AP; Loechner S; Rosen LS; Shanahan F; Parry D; Shumway S; Grabowsky JA; Freshwater T; Sorge C; Kang SP; Isaacs R; Munster PN
J Clin Oncol; 2015 Mar; 33(9):1060-6. PubMed ID: 25605849
[TBL] [Abstract] [Full Text] [Related]
18. Apoptosis of osteosarcoma cultures by the combination of the cyclin-dependent kinase inhibitor sch727965 and a heat shock protein 90 inhibitor.
Fu W; Sharma SS; Ma L; Chu B; Bui MM; Reed D; Pledger WJ
Cell Death Dis; 2013 Mar; 4(3):e566. PubMed ID: 23538447
[TBL] [Abstract] [Full Text] [Related]
19. The cyclin-dependent kinase inhibitor sch 727965 (dinacliclib) induces the apoptosis of osteosarcoma cells.
Fu W; Ma L; Chu B; Wang X; Bui MM; Gemmer J; Altiok S; Pledger WJ
Mol Cancer Ther; 2011 Jun; 10(6):1018-27. PubMed ID: 21490307
[TBL] [Abstract] [Full Text] [Related]
20. Radiation-induced rhabdomyosarcoma of the brainstem in a patient with neurofibromatosis type 2.
Carlson ML; Babovic-Vuksanovic D; Messiaen L; Scheithauer BW; Neff BA; Link MJ
J Neurosurg; 2010 Jan; 112(1):81-7. PubMed ID: 19575577
[TBL] [Abstract] [Full Text] [Related]
[Next]